Plain-English translation of NCT05839379 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a research study for children, adolescents, and young adults newly diagnosed with high-grade glioma or diffuse intrinsic pontine glioma (a serious brain tumor). The trial uses advanced genetic testing to understand what makes each patient's tumor unique, then assigns them to a targeted treatment plan based on those specific genetic findings. The goal is to match each patient with the treatment most likely to work for their particular tumor.
Standard treatments for aggressive brain tumors in children don't work the same way for everyone. By understanding the genetic profile of each tumor, doctors hope to give patients treatments tailored to their specific cancer, potentially improving outcomes and reducing unnecessary side effects.
You likely qualify if…
You likely don't qualify if…
After you enroll, your tumor tissue and a normal tissue sample (like blood or saliva) will be sent to specialized laboratories for comprehensive genetic testing. Based on the results of this testing, you will be assigned to one of several treatment arms designed specifically for your tumor's genetic profile. Throughout the trial, you will have blood tests, spinal fluid samples, brain imaging, and possibly additional tissue samples collected to monitor how you respond to treatment and to help researchers understand what factors predict success or treatment resistance.
AI-generated summary from trial data · Jul 12, 2026 · Not medical advice
United States